Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Psychopharmacology (Oxford, England)|December 17, 2022
A unified model of ketamine's dissociative and psychedelic propertiesMiriam Marguilho, Inês Figueiredo, Pedro Castro-RodriguesFrontiers in Psychology|December 5, 2015
From Thought to Action: How the Interplay Between Neuroscience and Phenomenology Changed Our Understanding of Obsessive-Compulsive DisorderJ Bernardo Barahona-Corrêa, Marta Camacho, Pedro Castro-Rodrigues, et al.Journal of Visualized Experiments : Jove|November 17, 2025
Cross-cultural Adaptation and Psychometric Validation of a Structured Interview for Psychiatric AssessmentSílvia Almeida, Pedro Castro-Rodrigues, J Bernardo Barahona-Corrêa, et al.Frontiers in Psychiatry|September 27, 2018
Criterion Validity of the Yale-Brown Obsessive-Compulsive Scale Second Edition for Diagnosis of Obsessive-Compulsive Disorder in AdultsPedro Castro-Rodrigues, Marta Camacho, Sílvia Almeida, et al.General Hospital Psychiatry|February 14, 2026
Ketamine combined with psychotherapy for treatment-resistant depression: Real-world outcomes and the role of subjective experienceRebeca Cohen, João Bastos, Catarina Cunha, et al.Nature Human Behaviour|May 19, 2022
Explicit knowledge of task structure is a primary determinant of human model-based actionPedro Castro-Rodrigues, Thomas Akam, Ivar Snorasson, et al.Brain, Behavior, and Immunity|June 12, 2026
Immune (dys)function in obsessive-compulsive disorderAna Maia, Nelson Descalço, Sara Fernandes, et al.Cureus|February 3, 2025
Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'Sorcha O'Connor, Kate Godfrey, Sara Reed, et al.Cureus|January 30, 2025
Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'Sorcha O'Connor, Kate Godfrey, Sara Reed, et al.Pageof 1